Showing results (41-50 of 117) with videos related to
Sort By:
Pageof 12
The Journal of Urology|June 7, 2006
The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followupDavid G McLeod, William A See, Ira Klimberg, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2005
Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer ProgrammeChris J Tyrrell, Heather Payne, William A See, et al.Journal of Cancer|August 1, 2013
Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from IndiaSudhir Rawal, Denise Young, Molly Williams, et al.Experimental Cell Research|September 29, 2007
Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cellsHongzhen Li, Jianjun Zhou, Jun Miki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failureAlexandra J Stewart, Howard I Scher, Ming-Hui Chen, et al.Urology|July 11, 2009
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancerOliver Sartor, David G McLeod, Susan Halabi, et al.BJU International|November 25, 2010
Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National DatabaseEmmanuel S Antonarakis, Yongmei Chen, Sally I Elsamanoudi, et al.The Journal of Urology|July 11, 2003
Diagnostic potential of serum proteomic patterns in prostate cancerLionel L Bañez, Premkala Prasanna, Leon Sun, et al.Urology|December 26, 2007
Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomyInger L Rosner, Lakshmi Ravindranath, Bungo Furusato, et al.Cancer Research|April 6, 2007
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimensJun Miki, Bungo Furusato, Hongzhen Li, et al.Pageof 12